Consortium Mission

Through collaborative work and partnership of patients, industry, regulators, academia, payers and other stakeholders, construct an ideal pathway to ensure that all born with serious genetic conditions can find their way to effective gene therapies.

Pathway Development

Moving AAV Gene Therapies Forward

 
 
Speech.jpg
 

Advocate

Partner with patients to lead patient engagement in AAV gene therapy for rare diseases.

 
group+icon.jpg
 

Collaborate

Work with the rare disease community and its partners to improve diagnosis rates and increase the availability of innovative AAV gene therapies.

 
logo (2).png
 

Navigate

Advance the field of AAV gene therapy by identifying solutions to barriers and work toward defining a clear regulatory roadmap.

 
integrate.jpg
 

Integrate

Build a model AAV gene therapy pathway for patients and families that is replicable and scalable.

Gus.jpg

Accelerating AAV Gene Therapy Development


Learn More →

Duchenne Muscular Dystrophy

Get In Touch